DaBoze: Success in mice is certainly better than failure, but as I'm sure you know, there have been literally THOUSANDS of treatments that have faired well in mice and failed in humans. Extracellular is also a good thing, but until we have TOX and until we have clinicals, neither of which we will have this year (and clinicals will likely be '16 now), we won't know for sure.
But let's talk about seeking alpha and Seymour's bike some more. That's what really matters.
News 
Market Data 
Discover 
